Marine Drugs (Jun 2012)

Marine Cyclotripeptide X-13 Promotes Angiogenesis in Zebrafish and Human Endothelial Cells via PI3K/Akt/eNOS Signaling Pathways

  • Zhong Pei,
  • Hong-Shuo Sun,
  • Li-Ping Wang,
  • Ji-Yan Pang,
  • Jing-Song Ou,
  • Jin-Sheng Zeng,
  • Ru-Xun Huang,
  • Guang-Lei Wang,
  • Yong-Cheng Lin,
  • Jing Li,
  • Cheng-Hui Ye,
  • Feng-Juan Su,
  • Xiao-Li Yao,
  • Zhong-Liang Xu,
  • Xi-Lin Lu

DOI
https://doi.org/10.3390/md10061307
Journal volume & issue
Vol. 10, no. 6
pp. 1307 – 1320

Abstract

Read online

Cyclotripeptide X-13 is a core of novel marine compound xyloallenoide A isolated from mangrove fungus <em>Xylaria</em> sp. (no. 2508). We found that X-13 dose-dependently induced angiogenesis in zebrafish embryos and in human endothelial cells, which was accompanied by increased phosphorylation of eNOS and Akt and NO release. Inhibition of PI3K/Akt/eNOS by LY294002 or l-NAME suppressed X-13-induced angiogenesis. The present work demonstrates that X-13 promotes angiogenesis via PI3K/Akt/eNOS pathways.

Keywords